Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single Arm, Single Dose Study to Characterize the Biodistribution of 124I-Labeled AT-03 in Select Organs in Patients With Systemic Amyloidosis

NCT05201911 is registered in ClinicalTrials.gov with Attralus, Inc. as lead sponsor.

NCT NCT05201911
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05201911 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single Arm, Single Dose Study to Characterize the Biodistribution of 124I-Labeled AT-03 in Select Organs in Patients With Systemic Amyloidosis
Lead sponsor
Attralus, Inc.
Phase
Phase 1
Overall status
Completed
Start date
November 30, 2021
Completion date
September 6, 2022
Enrollment
13 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

amyloidosis; systemic